Healthcare Triangle is trading at $6.96, up 8.24% in pre-market, with no clear catalyst identified. - No new company-specific announcement or clearly reported catalyst was identified for the October 29 pre-market rise. - The October 26 1-for-20 reverse stock split was the latest major event, announced as part of a plan to regain Nasdaq minimum-bid compliance; it predates this rise and does not establish its cause. - Negative software-sector context does not explain the rise; the reason remains unclear.